Pubblicazioni

Leader in Italia nella ricerca e nella
commercializzazione di kit diagnostici
per test farmacogenetici

2002, 2024

Fabio Canino et al., Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients

2002, 2024

Zahra Abrehdari-Tafreshi et al., The Role of miR-29a and miR-143 on the Anti-apoptotic MCL-1/cIAP-2 Genes Expression in EGFR Mutated Non-small Cell Lung Carcinoma Patients

1402, 2024

Lorenza Rimassa et al., Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition

1102, 2024

Angela Santoro et al., Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs

202, 2024

Samantha Epistolio et al., Clinical Relevance and Interplay between miRNAs in Influencing Glioblastoma Multiforme Prognosis

2701, 2024

Combination of Maria Cristina Sini et al., Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population

1901, 2024

Marcella Barbarino et al., Comparison of two mechanical disaggregation methods of fresh lung tissues for extraction of high-quality RNA

1701, 2024

Federica Grillo et al., Correction to: Prevalence and type of MMR expression heterogeneity in colorectal adenocarcinoma: therapeutic implications and reporting

601, 2024

Matteo Pallocca et al., Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres

301, 2024

Michele Simbolo et al., Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives

301, 2024

Federica Grillo et al., BRAFV600E immunohistochemistry can reliably substitute BRAF molecular testing in the Lynch syndrome screening algorithm in colorectal cancer

101, 2024

Margareta Radi? Antolic et al., U?estalost idh1/2 mutacija u bolesnika s dijagnozom akutne mijeloi?ne leukemije – pilot studija kbc zagreb

Precedente 456 Successivo

Pubblicazioni

Leader in Italia nella ricerca e nella
commercializzazione di kit diagnostici
per test farmacogenetici

Cerca pubblicazione

Filtra per anno

Cerca per primo autore

Cerca per linea

Pubblicazioni

Leader in Italia nella ricerca e nella commercializzazione di kit diagnostici per test farmacogenetici

Cerca pubblicazione

Filtra per anno

Cerca per primo autore

Cerca per linea

Leader in Italia nella ricerca e nella
commercializzazione di kit diagnostici
per test farmacogenetici